Lithium Americas Corp vs Koninklijke Philips NV — how do they compare? Lithium Americas Corp trades at $3.06 (market cap $1.01B), while Koninklijke Philips NV trades at $26.77 (market cap $26.19B). The key difference: Koninklijke Philips NV is far larger — about 25.9× Lithium Americas Corp's market cap, and Koninklijke Philips NV pays a 3.79% dividend while Lithium Americas Corp pays none. Which is the better fit depends on your goals.
| LAC | PHG | |
|---|---|---|
Market Cap | $1.01B | $26.19B |
Sector | Basic Materials | Health |
52-Week High | $10.05 | $32.91 |
52-Week Low | $2.55 | $24.54 |
Enterprise Value | $1.13B | $32.46B |
Dividend Yield | — | 3.79% |
Signals from Pluang's Aura AI — not financial advice
Lithium Americas (LAC) trades at $2.90, down 1.69% amid bearish technical signals despite recent earnings beats. The company shows negative profitability with ROE at -11.35% and net income of -$122.09M for 2025, though it maintains strong financing cash flow of $1.14B. Construction milestones at Thacker Pass project progress, with 2026 expected to be pivotal for operational developments according to company guidance.
Investment outlook balances significant project potential against substantial execution risks. While analyst consensus leans positive with 47% buy ratings and no sell recommendations, the stock faces headwinds from negative cash flow from operations and high capital expenditure requirements. Key risks include dilution from share issuances and sensitivity to lithium market dynamics.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →